The most frequently reported any-grade adverse events (≥10%) included diarrhea, nausea, vomiting, fatigue, ECG QT prolongation, elevations in AST and ALT, increased amylase and blood creatinine (or acute kidney injury), decreased appetite, and anemia. This evidence concerns the gene GPT and anemia.